 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/08/2026 |
$4.67 |
$4.76 |
$4.00 |
$4.28 |
86.00K | | 09/09/2026 |
$4.26 |
$4.30 |
$4.11 |
$4.21 |
26.80K | | 09/10/2026 |
$4.15 |
$4.20 |
$4.06 |
$4.07 |
15.50K | | 09/11/2026 |
$4.07 |
$4.11 |
$3.84 |
$3.90 |
37.70K | | 09/14/2026 |
$4.00 |
$4.33 |
$3.85 |
$4.33 |
66.80K |
 |
| Xenetic Biosciences, Inc. is a biopharmaceutical company. Co. is focused on advancing immune-oncology technologies addressing hard to treat cancers. Co.'s DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression. It is focused on advancing the development of its DNase platform toward a first-in-human, multicenter, dose escalation and dose-expansion study of IV rhDNase I in subjects with locally advanced or metastatic solid tumors. | |
 |

Xenetic Biosciences (XBIO) has the following price history information. Looking back at XBIO historical stock prices for the last five trading days, on September 08, 2026, XBIO opened at $4.67, traded as high as $4.76 and as low as $4.00, and closed at $4.28. Trading volume was a total of 86.00K shares. On September 09, 2026, XBIO opened at $4.26, traded as high as $4.30 and as low as $4.11, and closed at $4.21. Trading volume was a total of 26.80K shares. On September 10, 2026, XBIO opened at $4.15, traded as high as $4.20 and as low as $4.06, and closed at $4.07. Trading volume was a total of 15.50K shares. On September 11, 2026, XBIO opened at $4.07, traded as high as $4.11 and as low as $3.84, and closed at $3.90. Trading volume was a total of 37.70K shares. On September 14, 2026, XBIO opened at $4.00, traded as high as $4.33 and as low as $3.85, and closed at $4.33. Trading volume was a total of 66.80K shares.
XBIO Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenetic Biosciences shares, starting with a $10,000 purchase of XBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/16/2016 |
|
| End date: |
09/14/2026 |
|
| Start price/share: |
$414.00 |
|
| End price/share: |
$4.33 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.95% |
|
| Average Annual Total Return: |
-36.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$104.60 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 09/08/2026 | $4.28 | | 09/09/2026 | $4.21 | | 09/10/2026 | $4.07 | | 09/11/2026 | $3.90 | | 09/14/2026 | $4.33 |
|
 |